Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
ZTO Express
ZTO
$17.6B
| $5.02M | ﹤0.01% |
163,616
-2,752
| -2% | -$79K |
|
2377
Columbia Financial
CLBK
$1.21B
| $5.01M | ﹤0.01% |
270,783
-35,725
| -12% | -$639K |
|
|
GPMT
2378
Granite Point Mortgage Trust
GPMT
$58.8M
| $5M | ﹤0.01% |
379,332
+778
| +0.2% | +$10.7K |
|
2379
HealthStream
HSTM
$829M
| $4.99M | ﹤0.01% |
174,519
-1,316
| -0.7% | -$38.4K |
|
2380
Camden National
CAC
$990M
| $4.96M | ﹤0.01% |
103,621
+536
| +0.5% | +$24.7K |
|
|
ROVR
2381
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $4.93M | ﹤0.01% |
+362,839
| New | +$4.47M |
|
2382
RE/MAX Holdings
RMAX
$263M
| $4.93M | ﹤0.01% |
158,083
+2,143
| +1% | +$71.2K |
|
|
LTCH
2383
DELISTED
Latch, Inc. Common Stock
LTCH
| $4.91M | ﹤0.01% |
+436,012
| New | +$5.38M |
|
|
VBIV
2384
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $4.9M | ﹤0.01% |
52,496
+1,309
| +3% | +$124K |
|
|
HONE
2385
DELISTED
HarborOne Bancorp
HONE
| $4.9M | ﹤0.01% |
348,714
-25,179
| -7% | -$349K |
|
|
ENDP
2386
DELISTED
Endo International plc
ENDP
| $4.89M | ﹤0.01% |
1,510,128
-191,211
| -11% | -$675K |
|
|
FRTA
2387
DELISTED
Forterra, Inc
FRTA
| $4.88M | ﹤0.01% |
207,270
+55,663
| +37% | +$1.31M |
|
|
AEVA
2388
Aeva Technologies
AEVA
$1.75B
| $4.86M | ﹤0.01% |
122,324
+23,676
| +24% | +$1.1M |
|
|
SNCY
2389
DELISTED
Sun Country Airlines
SNCY
| $4.83M | ﹤0.01% |
144,156
+1,119
| +0.8% | +$37.3K |
|
|
VERV
2390
DELISTED
Verve Therapeutics
VERV
| $4.83M | ﹤0.01% |
+102,810
| New | +$6.05M |
|
|
HTBK
2391
DELISTED
Heritage Commerce
HTBK
| $4.82M | ﹤0.01% |
414,560
+3,497
| +0.9% | +$39.1K |
|
2392
Turning Point Brands
TPB
$1.73B
| $4.81M | ﹤0.01% |
100,797
+13,101
| +15% | +$628K |
|
|
ATCO
2393
DELISTED
Atlas Corp.
ATCO
| $4.81M | ﹤0.01% |
316,854
-44,272
| -12% | -$633K |
|
2394
Republic Bancorp
RBCAA
$1.91B
| $4.81M | ﹤0.01% |
94,988
-1,970
| -2% | -$96.5K |
|
2395
DMC Global
BOOM
$155M
| $4.81M | ﹤0.01% |
130,351
+1,252
| +1% | +$54.3K |
|
2396
Gossamer Bio
GOSS
$83.3M
| $4.81M | ﹤0.01% |
382,567
+20,237
| +6% | +$186K |
|
2397
Community Trust Bancorp
CTBI
$1.42B
| $4.81M | ﹤0.01% |
114,162
+7,936
| +7% | +$321K |
|
2398
Personalis
PSNL
$1.54B
| $4.81M | ﹤0.01% |
249,801
+44,428
| +22% | +$929K |
|
2399
Amphastar Pharmaceuticals
AMPH
$850M
| $4.8M | ﹤0.01% |
252,767
-620
| -0.2% | -$12.1K |
|
|
FFIC
2400
DELISTED
Flushing Financial
FFIC
| $4.76M | ﹤0.01% |
210,818
+1,121
| +0.5% | +$24.8K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.